Prelude Capital Management’s HCA Healthcare HCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $561K | Buy |
1,186
+214
| +22% | +$108K | 0.04% | 465 |
|
|
2025
Q4 | $454K | Sell |
972
-3,683
| -79% | -$1.71M | 0.03% | 581 |
|
|
2025
Q3 | $1.98M | Sell |
4,655
-945
| -17% | -$366K | 0.15% | 165 |
|
|
2025
Q2 | $2.15M | Buy |
5,600
+32
| +0.6% | +$11.5K | 0.21% | 125 |
|
|
2025
Q1 | $1.92M | Buy |
5,568
+536
| +11% | +$172K | 0.15% | 155 |
|
|
2024
Q4 | $1.51M | Buy |
5,032
+2,059
| +69% | +$720K | 0.09% | 255 |
|
|
2024
Q3 | $1.21M | Sell |
2,973
-2,870
| -49% | -$1.05M | 0.07% | 335 |
|
|
2024
Q2 | $1.88M | Sell |
5,843
-10,031
| -63% | -$3.26M | 0.13% | 203 |
|
|
2024
Q1 | $5.29M | Sell |
15,874
-16,620
| -51% | -$5.08M | 0.28% | 56 |
|
|
2023
Q4 | $8.8M | Buy |
32,494
+5,122
| +19% | +$1.27M | 0.58% | 21 |
|
|
2023
Q3 | $6.73M | Buy |
27,372
+20,086
| +276% | +$5.5M | 0.44% | 28 |
|
|
2023
Q2 | $2.21M | Sell |
7,286
-9,513
| -57% | -$2.64M | 0.14% | 180 |
|
|
2023
Q1 | $4.43M | Sell |
16,799
-5,207
| -24% | -$1.32M | 0.27% | 72 |
|
|
2022
Q4 | $5.28M | Sell |
22,006
-4,795
| -18% | -$1.07M | 0.27% | 70 |
|
|
2022
Q3 | $4.93M | Buy |
26,801
+3,016
| +13% | +$601K | 0.18% | 87 |
|
|
2022
Q2 | $4M | Buy |
23,785
+4,013
| +20% | +$862K | 0.11% | 140 |
|
|
2022
Q1 | $4.96M | Buy |
19,772
+18,531
| +1,493% | +$4.65M | 0.14% | 128 |
|
|
2021
Q4 | $319K | Sell |
1,241
-2,062
| -62% | -$505K | 0.01% | 1281 |
|
|
2021
Q3 | $802K | Buy |
+3,303
| New | +$808K | 0.02% | 659 |
|
|
2021
Q2 | – | Sell |
-17,456
| Closed | -$3.29M | – | 1769 |
|
|
2021
Q1 | $3.29M | Buy |
17,456
+10,708
| +159% | +$1.89M | 0.08% | 178 |
|
|
2020
Q4 | $1.11M | Buy |
6,748
+2,769
| +70% | +$405K | 0.03% | 452 |
|
|
2020
Q3 | $496K | Sell |
3,979
-436
| -10% | -$54K | 0.02% | 445 |
|
|
2020
Q2 | $429K | Buy |
+4,415
| New | +$459K | 0.02% | 508 |
|
|
2020
Q1 | – | Sell |
-517
| Closed | -$76K | – | 1662 |
|
|
2019
Q4 | $76K | Sell |
517
-1,858
| -78% | -$250K | ﹤0.01% | 1200 |
|
|
2019
Q3 | $286K | Buy |
2,375
+1,136
| +92% | +$147K | 0.01% | 675 |
|
|
2019
Q2 | $167K | Sell |
1,239
-268
| -18% | -$33.9K | 0.01% | 793 |
|
|
2019
Q1 | $196K | Sell |
1,507
-824
| -35% | -$111K | 0.01% | 717 |
|
|
2018
Q4 | $290K | Sell |
2,331
-2,612
| -53% | -$351K | 0.02% | 618 |
|
|
2018
Q3 | $688K | Sell |
4,943
-3,062
| -38% | -$381K | 0.04% | 450 |
|
|
2018
Q2 | $821K | Buy |
8,005
+3,869
| +94% | +$391K | 0.05% | 386 |
|
|
2018
Q1 | $401K | Buy |
+4,136
| New | +$401K | 0.03% | 498 |
|
|
2016
Q4 | – | Sell |
-1,837
| Closed | -$139K | – | 1647 |
|
|
2016
Q3 | $139K | Buy |
1,837
+1,197
| +187% | +$91.7K | 0.01% | 702 |
|
|
2016
Q2 | $49K | Buy |
+640
| New | +$50.5K | 0.01% | 1014 |
|
|
2015
Q3 | – | Sell |
-993
| Closed | -$90K | – | 1603 |
|
|
2015
Q2 | $90K | Buy |
+993
| New | +$79.6K | 0.01% | 918 |
|
|
2015
Q1 | – | Sell |
-250
| Closed | -$18K | – | 2023 |
|
|
2014
Q4 | $18K | Sell |
250
-940
| -79% | -$66.1K | ﹤0.01% | 1755 |
|
|
2014
Q3 | $84K | Buy |
+1,190
| New | +$78.6K | 0.01% | 1162 |
|
|
2014
Q1 | – | Sell |
-13,450
| Closed | -$642K | – | 1970 |
|
|
2013
Q4 | $642K | Sell |
13,450
-6,300
| -32% | -$291K | 0.11% | 269 |
|
|
2013
Q3 | $844K | Buy |
19,750
+18,750
| +1,875% | +$733K | 0.14% | 178 |
|
|
2013
Q2 | $36K | Buy |
+1,000
| New | +$38.7K | 0.01% | 859 |
|
Other funds holding HCA
VCM
VPM
Prelude Capital Management's HCA Position: Q1 2026 in Review
Prelude Capital Management increased its HCA Healthcare (HCA) stake by 22% in Q1 2026, buying an estimated $108K and bringing the position to 1,186 shares worth $561K. The position accounts for 0.04% of the portfolio, ranked #465.
Prelude Capital Management first reported a position in HCA in Q2 2013 and has held it in 39 quarters since. The position peaked at $8.8M in Q4 2023. 1,414 funds tracked by Wall St. Rank hold HCA as of Q1 2026.
- Prelude Capital Management held 1,186 shares of HCA Healthcare worth $561K as of Q1 2026.
- Prelude Capital Management bought 214 HCA Healthcare shares in Q1 2026, an estimated $108K.
- HCA Healthcare made up 0.04% of Prelude Capital Management's portfolio in Q1 2026, its #465 holding.
- Prelude Capital Management first reported a position in HCA Healthcare in Q2 2013 and has held it in 39 quarters since.
- Prelude Capital Management's HCA Healthcare position peaked at $8.8M in Q4 2023.
- 1,414 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.
Based on Prelude Capital Management's 13F filing for Q1 2026, filed 15 May 2026.